Electronic Brachytherapy A Viable Option For Early Stage Breast Cancer, According To

[News]

Early clinical experience with the FDA cleared Axxent(R) Electronic Brachytherapy (eBx) System from Xoft demonstrates that the X-Ray-based, non-isotopic treatment is a viable option for adjuvant therapy for early-stage breast cancer. Initial data from this multi-center study was presented at the 2008 Breast Cancer Symposium here in Washington, DC.

More... (http://www.medicalnewstoday.com/articles/120719.php)